Stocks
Cyteir Therapeutics, Inc.CYT
NASDAQHealthcareBiotechnology$3.02-2.27%
A clinical-stage biotechnology company focused on developing therapies that target DNA repair mechanisms to treat cancer. Its research centers on small‑molecule drugs designed to exploit synthetic lethality in tumor cells, with candidates evaluated in early-stage clinical trials. Investors track the...
Market Cap: $108.7M52W Range: $1.65 – $3.19
Congressional Interest in Cyteir Therapeutics, Inc. (CYT)
1 member of Congress has disclosed 1 trade in Cyteir Therapeutics, Inc. (CYT), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading CYT?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-05-28 | MICHAEL T. MCCAUL | sell | $1K – $15K |